Cargando…

Hematology and Immune-Related Disorders

Detalles Bibliográficos
Autor principal:	Javinsky, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271196/ http://dx.doi.org/10.1016/B978-1-4377-0660-4.00025-9

Ejemplares similares

Hematologic Disorders
por: Varon, Joseph, et al.
Publicado: (2009)

Hematologic Disorders
por: Varon, Joseph
Publicado: (2016)

Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
por: Găman, Amelia Maria
Publicado: (2023)

Hematological Side Effects of Immune Checkpoint Inhibitors: The Example of Immune-Related Thrombocytopenia
por: Calvo, Roser
Publicado: (2019)

Hepatic Manifestations in Hematological Disorders
por: Murakami, Jun, et al.
Publicado: (2013)

LAIR1, an ITIM-Containing Receptor Involved in Immune Disorders and in Hematological Neoplasms
por: Van Laethem, François, et al.
Publicado: (2022)

Extracellular Vesicles in Hematological Disorders
por: Aharon, Anat, et al.
Publicado: (2014)

Hematological disorders and pulmonary hypertension
por: Mathew, Rajamma, et al.
Publicado: (2016)

Molecular Immunology in Hematological Disorders
por: Takami, Akiyoshi
Publicado: (2022)

Ocular Manifestations in Hematological Disorders
por: Bouazza, Mohamed, et al.
Publicado: (2022)

Immune Therapies for Hematologic Malignancies
por: Olnes, Matthew J.
Publicado: (2021)

Immune Microenvironment in Hematologic Malignancies
por: Arandi, Nargess, et al.
Publicado: (2023)

Indications and Outcomes of Splenectomy for Hematological Disorders
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

BMC Blood Disorders becomes BMC Hematology: evolving along with the hematology field
por: Chap, Christna
Publicado: (2013)

Could Immune Checkpoint Disorders and EBV Reactivation Be Connected in the Development of Hematological Malignancies in Immunodeficient Patients?
por: Mertowska, Paulina, et al.
Publicado: (2023)

Clinical and Hematological Predictors of High-Grade Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors
por: Manne, Ashish, et al.
Publicado: (2021)

Skeletal scintigraphy manifestations of hematologic disorders
por: Solav, Shrikant V, et al.
Publicado: (2012)

Silibinin: an old drug for hematological disorders
por: Zou, Hai, et al.
Publicado: (2017)

Hematologic Complications of Immune Checkpoint Inhibitors
por: Davis, Elizabeth J., et al.
Publicado: (2019)

Targeting immune checkpoints in hematological malignancies
por: Salik, Basit, et al.
Publicado: (2020)

Hematologic complications of immune checkpoint inhibitors
por: Kroll, Michael H., et al.
Publicado: (2022)

Hematology, the lymphatic system, and the immune system
Publicado: (1993)

Hematological Disorders in Patients with Systemic Lupus Erythematosus
por: Bashal, Fozya
Publicado: (2013)

Safety of bronchoscopy in patients with malignant hematologic disorders
por: Uruga, Hironori, et al.
Publicado: (2020)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
por: Zhuang, Junling, et al.
Publicado: (2020)

Alterations in the ribosomal machinery in cancer and hematologic disorders
por: Shenoy, Niraj, et al.
Publicado: (2012)

Role of Partial Splenectomy in Hematologic Childhood Disorders
por: Attina’, Giorgio, et al.
Publicado: (2021)

Fertility preservation in female patients with hematological disorders
por: Wu, Dan, et al.
Publicado: (2022)

COVID-19 Vaccines and Autoimmune Hematologic Disorders
por: Mingot-Castellano, María Eva, et al.
Publicado: (2022)

Telomere biology: from disorders to hematological diseases
por: Roka, Kleoniki, et al.
Publicado: (2023)

Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
por: Hradska, Katarina, et al.
Publicado: (2021)

Primate Erythroparvovirus 1 Infection in Patients with Hematological Disorders
por: Krumova, Stefka, et al.
Publicado: (2022)

Redox stress in COVID-19: Implications for hematologic disorders
por: Yang, Moua
Publicado: (2022)

Evaluation of membrane‐based therapeutic plasma exchange as adjunctive treatment for immune‐mediated hematologic disorders in dogs
por: Francey, Thierry, et al.
Publicado: (2021)

Pediatric cholecystectomy for symptomatic gallstones unrelated to hematologic disorder
por: Suh, Sang Gyun, et al.
Publicado: (2016)

Hematologic disorders associated with COVID-19: a review
por: Rahi, Mandeep Singh, et al.
Publicado: (2021)

Diagnostic performance of classification trees and hematological functions in hematologic disorders: an application of multidimensional scaling and cluster analysis
por: Rahim, Fakher, et al.
Publicado: (2021)

Immune-Mediated Cutaneous Paraneoplastic Syndromes Associated With Hematologic Malignancies: Skin as a Mirror of Hematologic Neoplasms
por: Alvarez-Payares, Jose C, et al.
Publicado: (2021)

Adverse Hematological Effects of COVID-19 Vaccination and Pathomechanisms of Low Acquired Immunity in Patients with Hematological Malignancies
por: Yazdani, Armand N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gajv8jcbld42kaqmmrv9js9j0g